Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid

被引:471
作者
Chimon, Sandra [1 ]
Shaibat, Medhat A. [1 ]
Jones, Christopher R. [1 ]
Calero, Diana C. [1 ]
Aizezi, Buzulagu [1 ]
Ishii, Yoshitaka [1 ]
机构
[1] Univ Illinois, Dept Chem, Chicago, IL 60607 USA
关键词
D O I
10.1038/nsmb1345
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diffusible subfibrillar aggregates of amyloid proteins are potent neurotoxins and primary suspects in amyloid diseases including Alzheimer's disease. Despite widespread interest, the molecular structures of the amyloid intermediates and the conformational conversions in amyloid misfolding are poorly understood. Here we present a molecular-level examination of sequence-specific secondary structures and supramolecular structures of a neurotoxic amyloid intermediate of the 40-residue beta-amyloid (A beta) peptide involved in Alzheimer's disease. Using solid-state NMR and electron microscopy, we show that, before fibrillization, natively unstructured monomeric A beta is subject to large conformational changes into a spherical amyloid intermediate of 15-35 nm diameter, which has predominantly parallel beta-sheet structures. Structural comparison with A beta fibrils demonstrates that formation of this beta-sheet intermediate (I-beta) largely defines conformational transitions in amyloid misfolding. Neurotoxicity assays on PC12 cells show that I-beta shows higher toxicity than the fibril, indicating that the beta-sheet formation may trigger neurotoxicity.
引用
收藏
页码:1157 / 1164
页数:8
相关论文
共 51 条
[42]   Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases [J].
Selkoe, DJ .
NATURE CELL BIOLOGY, 2004, 6 (11) :1054-1061
[43]  
Shearman MS, 1999, METHOD ENZYMOL, V309, P716
[44]   EMPIRICAL CORRELATION BETWEEN PROTEIN BACKBONE CONFORMATION AND C-ALPHA AND C-BETA C-13 NUCLEAR-MAGNETIC-RESONANCE CHEMICAL-SHIFTS [J].
SPERA, S ;
BAX, A .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (14) :5490-5492
[45]   Slowed enzymatic turnover allows characterization of intermediates by solid-state NMR [J].
Studelska, DR ;
McDowell, LM ;
Espe, MP ;
Klug, CA ;
Schaefer, J .
BIOCHEMISTRY, 1997, 36 (50) :15555-15560
[46]   From the globular to the fibrous state: protein structure and structural conversion in amyloid formation [J].
Sunde, M ;
Blake, CCF .
QUARTERLY REVIEWS OF BIOPHYSICS, 1998, 31 (01) :1-+
[47]   Amyloid beta-protein fibrillogenesis - Detection of a protofibrillar intermediate [J].
Walsh, DM ;
Lomakin, A ;
Benedek, GB ;
Condron, MM ;
Teplow, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22364-22372
[48]   Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo [J].
Walsh, DM ;
Klyubin, I ;
Fadeeva, JV ;
Cullen, WK ;
Anwyl, R ;
Wolfe, MS ;
Rowan, MJ ;
Selkoe, DJ .
NATURE, 2002, 416 (6880) :535-539
[49]  
Weliky DP, 1999, NAT STRUCT BIOL, V6, P141
[50]   H-1, C-13 AND N-15 RANDOM COIL NMR CHEMICAL-SHIFTS OF THE COMMON AMINO-ACIDS .1. INVESTIGATIONS OF NEAREST-NEIGHBOR EFFECTS [J].
WISHART, DS ;
BIGAM, CG ;
HOLM, A ;
HODGES, RS ;
SYKES, BD .
JOURNAL OF BIOMOLECULAR NMR, 1995, 5 (01) :67-81